Why it’s on the radar
Anaheim Bio raised funding a Series A round of $43M, per PR Newswire — "Anaheim Bio Launches with €40 Million Series A Financing to Advance ANA-1 for Calcium Pyrophosphate Deposition Disease into the Clinic".
Original discovery source: prnewswire-vc · Nov 7, 2026
Deterministic signals Startup Radar has derived from hiring, GitHub and website activity, never inferred, never scored.
Tracking started
Tracking started, no notable change detected yet.
Every event Startup Radar has recorded for Anaheim Bio, most recent first.
Anaheim Bio Launches with €40 Million Series A Financing to Advance ANA-1 for Calcium Pyrophosphate Deposition Disease into the Clinic
a Series A round, $43M